COVID-19: New ECMO to be developed and introduced to the field: National Cardiovascular Research Center
Category: flu
COVID-19: Demonstrate virus reduction effect: Plasmacluster technology
AstraZeneca: Corona vaccine discontinued: suspected adverse reaction
Nippon Metal Industry: Virus decreased by 99.9% in 30 minutes: Mechanism of air purifier
Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19